SLNO — Soleno Therapeutics Share News
0.000.00%
Last trade - 00:00- $2.76bn
- $2.56bn
- $190.41m
Soleno jumps as Nuerocrine strikes $2.9 bln takeover deal
Brief: Neurocrine To Acquire Soleno Therapeutics, Expanding Its Endocrinology And Rare Disease Portfolio
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Deals of the day-Mergers and acquisitions
Soleno jumps on report of potential $2.5 billion Nuerocrine deal
Neurocrine nears $2.5 billion deal for Soleno Therapeutics, FT reports (updated)
Neurocrine nears $2.5 billion deal for Soleno Therapeutics, FT reports
U.S. STOCKS ON THE MOVE-Enovis, Cheniere, Packaging Corp of America
U.S. STOCKS ON THE MOVE-Qnity, J.M. Smucker, Vistra
Soleno Therapeutics shares rise on CFO appointment
U.S. RESEARCH ROUNDUP-Arcellx, Costar Group, Magnite
Soleno Therapeutics reports FY profit for 2025
Brief: Soleno Therapeutics Q4 EPS USD 0.8
U.S. RESEARCH ROUNDUP-Cencora, Kennametal, Regeneron Pharmaceuticals
U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners
Soleno Therapeutics up on forecasting preliminary 2025 Vykat XR sales above estimates
Oppenheimer starts Aardvark with 'outperform' on differentiated obesity franchise
Soleno hits monthly high after $100 million share buyback deal
U.S. STOCKS ON THE MOVE-Nebius, Estee Lauder, Soleno